Opendata, web and dolomites

QS Mobile

Setting a standard for personal digital sperm analysis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 QS Mobile project word cloud

Explore the words cloud of the QS Mobile project. It provides you a very rough idea of what is the project "QS Mobile" about.

market    quality    biophos    afford    b2c    proposition    semen    infertility    secure    giving    industry    automating    inconvenient    combines    cheaply    consuming    affordable    classes    performed    concentration    precision    b2b    intends    motility    accurately    smartphones    manufacturing    levels    revenues    children    validated    planning    video    channels    15    treatments    swiss    solution    annual    that    automated    sperm    germany    image    disrupt    time    removing    covers    qs    commercialized    types    feasibility    morphology    chances    lab    days    errors    tests    undergoing    sales    either    switzerland    manual    homes    mobile    fertility    visits    clip    installed    sme    20    takes    reliability    289    comfort    qualisperm    exclusively    performing    conception    spermatozoa    men    217    globally    serve    optics    carry    male    compact    total    labour    2027    standardized    habits    home    hospitals    don    6m    labs    privacy    microfluidics    device   

Project "QS Mobile" data sheet

The following table provides information about the project.

Coordinator
BIOPHOS SA 

Organization address
address: PARC SCIENTIFIQUE EPFL PSE
city: LAUSANNE
postcode: 1015
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://www.biophos.ch
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2018-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOPHOS SA CH (LAUSANNE) coordinator 50˙000.00

Map

 Project objective

QS Mobile is a novel clip-on device for smartphones for male sperm analysis. QS Mobile combines microfluidics technology, compact optics & advanced video image analysis to make sperm tests automated, removing the manual labour errors & providing precision & reliability levels comparable to labs. QS Mobile is the only solution that that covers all three types of sperm measurements required by WHO— concentration, different motility classes & spermatozoa morphology analysis. QS Mobile addresses the problem of time-consuming, inconvenient and not fully standardized tests of male infertility. Male infertility tests are currently performed exclusively in labs, and it takes several visits & several days to get a result. With QS Mobile male fertility tests can be carried out at home quickly, accurately & more cheaply than in the lab. It is targeted at men who are planning children, undergoing fertility treatments or interested to change their habits to increase their chances of conception. QS Mobile can also be used by hospitals that either don’t have or cannot afford a dedicated fertility lab. QS Mobile is developed by Biophos—a Swiss SME that commercialized QualiSperm—an industry-recognized advanced semen analysis technology installed in 15 labs in Germany & Switzerland & performing 20,000 sperm quality tests per year. With QS Mobile, Biophos intends to disrupt the market of male fertility tests by fully automating them and giving the affordable & reliable testing device to the men who need it, so that they can carry out the tests in privacy & comfort of their homes. By 2027 Biophos intends to serve 15-20% of total market with €217.2-289.6m annual revenues globally. In this phase 1 feasibility study Biophos will validated the B2C go-to-market approach & develop a value proposition for B2B market, develop sales & distribution channels & secure manufacturing partnerships.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "QS MOBILE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "QS MOBILE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

PRIDIKTIV (2017)

Pridiktiv - Exploring European expansion through 4 pilot studies

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More